Table 2.

HMGB1 and calreticulin expressions on tumors between patients with and without preoperative chemoradiotherapy

HMGB-1 (n = 88)HMGB-1–weak (n = 42)HMGB-1–strong (n = 46)
Operation alone (n = 43)2617
Operation + NeoCRT (n = 45)1629P = 0.04 (χ2 test)
Calreticulin (n = 88)Calreticulin–weak (n = 47)Calreticulin–strong (n = 41)
Operation alone (n = 43)2320
Operation + NeoCRT (n = 45)2421P = 0.85 (χ2 test)

NOTE: HMGB1 and calreticulin expressions on tumors between patients with preoperative chemotherapy (n = 45, operation + NeoCRT) and without preoperative chemoradiotherapy (n = 43, operation alone) are shown.